论文部分内容阅读
金龙胶囊是由“现代鲜药第一家”北京建生药业有限公司研发生产,于1998年正式上市。金龙胶囊以名贵鲜活药材为主要原料,采取低温冷冻现代生化分离提取技术,保持鲜药特有的活性成分,在肝癌治疗方面疗效确切,于2001年被国家药典委员会推选为.“中华特色药”。为总结金龙胶囊的临床应用经验,促进金龙胶囊临床研究的学术交流,评价金龙胶囊上市后用药安全性及患者的生存获益,鼓励临床医生的创新治疗方案,更好地服务于患者,《中国肿瘤临床》编辑部与中国癌症基金会建生专项基金办公室联合举办第二届“建生杯”——金龙胶囊临床应用有奖征文活动,现将有关事项通知如下。
Jinlong Capsule is developed and produced by Beijing Jiansheng Pharmaceutical Co., Ltd. by the first “Modern Fresh Medicine” and was officially launched in 1998. Jinlong capsule with fresh and precious medicinal herbs as the main raw material, to take cold frozen modern biochemical separation and extraction technology to maintain the unique active ingredients of fresh herbs in the treatment of liver cancer curative effect is exact, in 2001 by the State Pharmacopoeia Commission elected as. “. In order to summarize the clinical application experience of Jinlong Capsule and promote the academic exchange of clinical research of Jinlong Capsule, evaluate the safety of drug use and the survival benefit of patients after the listing of Jinlong Capsule, encourage clinicians to innovate treatment programs and better serve their patients. ”China Oncology Clinical “editorial department and the China Cancer Foundation built-in special fund office jointly organized the second ” Health Cup "- Jinlong Capsule Clinical Application Award essay activities, the relevant matters are as follows.